Getting to Transplant Remains Goal in Relapsed/Refractory Hodgkin Lymphoma

As part of our coverage of the ASH Annual Meeting, we are discussing novel agents and strategies for relapsed/refractory Hodgkin lymphoma.

Source: CancerNetwork - December 2, 2016 Category: Cancer & Oncology Authors: Craig H. Moskowitz, MD Tags: Conferences/ASH 2016 Hematologic Malignancies Leukemia & Lymphoma Source Type: news